Premature IP Action Over Kennedy Trust's Remicade Tossed
By Kat Greene ( December 1, 2014, 8:44 PM EST) -- The Kennedy Trust for Rheumatology Research on Monday escaped a suit from a drugmaker that sought to have the court declare that its biosimilar arthritis medicine didn't infringe Kennedy's patents for Remicade when a judge found the two parties weren't actually adverse to one another yet....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.